These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 7709358
1. [The clinical efficacy and characteristics of the effect of prolonged-action theophyllines on the external respiratory function and hemodynamics of bronchial asthma patients]. Kakhnovskiĭ IM, Solomatin AS, Vdovina TI. Ter Arkh; 1995; 67(1):48-51. PubMed ID: 7709358 [No Abstract] [Full Text] [Related]
2. [The efficacy of theopek in bronchial asthma and chronic bronchitis]. Korzh OB. Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005 [Abstract] [Full Text] [Related]
3. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV, Nonikov VE, Belousov IuB. Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801 [Abstract] [Full Text] [Related]
4. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs]. Korzh OB, Vygovskiĭ VP, Stadnicheko RA, Borzhievskaia OE, Kopel'man EI, Kozak KM, Senyk RV, Vygovskiĭ IaV. Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707 [Abstract] [Full Text] [Related]
5. Respiratory and circulatory interactions of salbutamol and theophyllamine in asthmatic patients. Pihlajamäki K, Kanto J. Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):435-8. PubMed ID: 511418 [No Abstract] [Full Text] [Related]
6. [An evaluation of the efficacy of Beclometh in bronchial asthma patients]. Molostova TN, Zubkov MN, Pankratov VS, Vlasenko SIu. Ter Arkh; 1992 Nov; 64(3):64-6. PubMed ID: 1440281 [Abstract] [Full Text] [Related]
7. [The pharmacokinetics of theopek--a new Soviet prolonged-action drug form of theophylline--in patients with bronchial asthma]. Belousov IuB, Abazova FI, Kholodov LE, Chervinskaia TA, Sokolov AV. Farmakol Toksikol; 1989 Nov; 52(5):63-8. PubMed ID: 2599082 [Abstract] [Full Text] [Related]
8. [The usefulness of theophylline in the treatment of moderate-severe asthma]. Cebollero Rivas P, Garisa Rocha R, Bazo Fernández E, Colás Sanz C, Duce Gracia F. Rev Clin Esp; 1994 Apr; 194(4):288-90. PubMed ID: 8022993 [Abstract] [Full Text] [Related]
9. [Clinical experience with delayed-action salbutamol]. Zanotelli F. Minerva Med; 1976 Mar 31; 67(16):1019-22. PubMed ID: 1264374 [No Abstract] [Full Text] [Related]
10. The hemodynamic and respiratory effects of adrenaline and theophylline derivatives in bronchial asthma. Helander S, Lindell SE, Lindholm B, Söderholm B, Westling H. Scand J Respir Dis; 1967 Mar 31; 48(1):45-57. PubMed ID: 5183052 [No Abstract] [Full Text] [Related]
11. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms]. Tsoĭ AN, Bogovskiĭ BP, Gavrilenko LN, Kushkenbaeva BE, Kukes VG. Ter Arkh; 1990 Mar 31; 62(9):22-5. PubMed ID: 2281401 [No Abstract] [Full Text] [Related]
12. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction. Grassi V, Nicora M, Beretta A. Int J Clin Pharmacol Res; 1987 Mar 31; 7(5):337-44. PubMed ID: 3667006 [Abstract] [Full Text] [Related]
13. [Effects of theopek and saltos on cardiorespiratory system in bronchial asthma]. Kirillov MM, Shapovalova TG, Riabova AIu, Smoliak SB, Bochkareva LE, Kurnosova OF, Kazban OG. Klin Med (Mosk); 1999 Mar 31; 77(11):37-9. PubMed ID: 10635631 [Abstract] [Full Text] [Related]
14. [Clinical study to evaluate the efficacy and acceptability of long-acting theophylline in children with asthma]. Nelly RC. Rev Alerg Mex (1987); 1988 Mar 31; 35(1):17-21. PubMed ID: 3369674 [No Abstract] [Full Text] [Related]
15. [Prolonged-action theophylline in the treatment of bronchial asthma]. Ter Arkh; 1989 Mar 31; 61(8):30-7. PubMed ID: 2588163 [No Abstract] [Full Text] [Related]
16. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma]. Huerta JG, Moguel A. Rev Alerg Mex (1987); 1988 Mar 31; 35(2):41-6. PubMed ID: 3389490 [No Abstract] [Full Text] [Related]
17. [The anti-inflammatory action of an oral sustained-release theophylline preparation. Results of a clinical pilot study with low dosages]. Bodner A, Hens C, Moser C, Oster H. Arzneimittelforschung; 1998 May 31; 48(5A):617-24. PubMed ID: 9676355 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects. Utama I, Kreukniet J, Fokkens J, Serra R. Int J Clin Pharmacol Ther Toxicol; 1983 Jun 31; 21(6):292-6. PubMed ID: 6885203 [Abstract] [Full Text] [Related]
19. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type]. Melillo G, D'Amato G, Cocco G. Minerva Med; 1976 Mar 13; 67(15):964-8. PubMed ID: 1264368 [No Abstract] [Full Text] [Related]
20. [External respiratory functions during treatment of chronic pneumonia complicated by bronchial asthma]. Fesenko IP. Vrach Delo; 1984 Feb 13; (2):8-12. PubMed ID: 6202061 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]